<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7121811/results/search/drug/results.xml">
  <result pre="good ARV activity with nonsevere toxic effects in comparison with" exact="nevirapine" post="as the standard drug in positive control group (Ardestani"/>
  <result pre="in vitro was estimated mainly for ARV NPs combinations involving" exact="etravirine" post="NPs, whereby the combinations that showed large dose-reduction were"/>
  <result pre="a biodegradable carrier for loading with TFV in combination with" exact="efavirenz" post="or saquinavir, which resulted in pronounced combination drug effects,"/>
  <result pre="(0.01861 and 0.033 μg/mL, respectively) and showed comparable activity with" exact="emtricitabine" post="solution. Based on prolonged intracellular drug concentration and inhibition"/>
  <result pre="and reduced toxicity of ARV bioactives. Surface-functionalized mannosylated-PLGA NPs of" exact="lamivudine" post="(LVD) administered by intravenous route in a dose of"/>
  <result pre="pure NPs of the darunavir (DRV) and its boosting agent" exact="ritonavir" post="(RTV) encapsulated within film-coated MPs was reported, in which"/>
  <result pre="targeting mannose responsive particles prepared through the layer-by-layer coating of" exact="CaCO3" post="with concanavalin A (Con A) and glycogen, the one"/>
  <result pre="efficient central nervous system targeting. Senanayake et al. (2015) conjugated" exact="succinate" post="derivatives of NRTIs with cholesteryl-ε-polylysine nanogels. Nanogel conjugates of"/>
  <result pre="succinate derivatives of NRTIs with cholesteryl-ε-polylysine nanogels. Nanogel conjugates of" exact="zidovudine" post="(ZDV), LVD, and abacavir demonstrated tenfold suppression of reverse"/>
  <result pre="with cholesteryl-ε-polylysine nanogels. Nanogel conjugates of zidovudine (ZDV), LVD, and" exact="abacavir" post="demonstrated tenfold suppression of reverse transcriptase activity in HIV-infected"/>
  <result pre="the living cells (Amirkhanov et al. 2015). SeNPs decorated by" exact="ribavirin" post="(RBV), a broad-spectrum antiviral drug, protected cells during H1N1"/>
  <result pre="(Tang et al. 2018). Biomimetic supramolecular hexagonal-shaped nanoassemblies composed of" exact="chondroitin sulfate" post="formed by mixing hydrophobically modified chondroitin sulfate with α-cyclodextrin"/>
  <result pre="nanoassemblies composed of chondroitin sulfate formed by mixing hydrophobically modified" exact="chondroitin sulfate" post="with α-cyclodextrin in water showed improved antiviral activity against"/>
  <result pre="showed improved antiviral activity against HSV-2 compared to hydrophobically modified" exact="chondroitin sulfate" post="(Galus et al. 2016). ACV was found to increasingly"/>
  <result pre="C (Hang et al. 2015). Multifunctional SeNPs with baicalin and" exact="folic acid" post="surface-modifications designed for the targeted treatment of HBV-infected liver"/>
  <result pre="delivery system prepared by conjugating the liver-targeting peptide to PEGylated" exact="cyclosporine" post="A-encapsulated PLGA NPs effectively inhibited viral replication in vitro"/>
  <result pre="in mice and non-human primatesNPJ Vaccines201834610.1038/s41541-018-0086-030302284 BelgamwarAKhanSYeolePIntranasal chitosan-g-HPβCD nanoparticles of" exact="efavirenz" post="for the CNS targetingArtif Cells Nanomed Biotechnol20184637438610.1080/21691401.2017.131326628423949 BernasconiVBernocchiBYeLLeMQOmokanyeACarpentierRSchonKSaelensXStaeheliPBetbederDLyckeNPorous nanoparticles"/>
  <result pre="3Int J Nanomedicine201384303431424235828 GaldieroSFalangaAVitielloMCantisaniMMarraVGaldieroMSilver nanoparticles as potential antiviral agentsMolecules2011168894891810.3390/molecules1610889422024958 GalusAMalletJMLemboDCagnoVDjabourovMLortat-JacobHBouchemalKHexagonal-shaped" exact="chondroitin sulfate" post="self-assemblies have exalted anti-HSV-2 activityCarbohydr Polym201613611312010.1016/j.carbpol.2015.08.05426572336 GaoYKraftJCYuDHoRJYRecent developments of"/>
  <result pre="for the formulation and optimization of solid lipid nanoparticles of" exact="efavirenz" post="by high pressure homogenization using design of experiments for"/>
  <result pre="transmitted infection—an updateMicrobial Cell2016342043710.15698/mic2016.09.52728357379 IshiharaTKanekoKIshiharaTMizushimaTDevelopment of biodegradable nanoparticles for liver-specific" exact="ribavirin" post="deliveryJ Pharm Sci20141034005401110.1002/jps.2421925335768 IshwaryaRVaseeharanBAnuradhaRRekhaRGovindarajanMAlharbiNSKadaikunnanSKhaledJMBenelliGEco-friendly fabrication of Ag nanostructures using"/>
  <result pre="and nanoparticle vaccines against the respiratory syncytial virusVaccine201644510.3390/vaccines4040045 JoshyKSAlexSMSnigdhaSKalarikkalNPothenLAThomasSEncapsulation of" exact="zidovudine" post="in PF-68 coated alginate conjugate nanoparticles for anti-HIV drug"/>
  <result pre="carboxy methyl cellulose and compritol-PEG for antiretroviral drug deliveryCellulose2017244759477110.1007/s10570-017-1446-z JyothiKRBeloorJJoAMinhNNChoiTGKimJHAkterSLeeSKMaengCHBaikHHKangIHaJKimSSLiver-targeted" exact="cyclosporine" post="A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus"/>
  <result pre="of influenza infectionVet Sci201857110.3390/vetsci50300716165133 KumarPLakshmiYSBhaskarCGollaKKondapiAKImproved safety, bioavailability and pharmacokinetics of" exact="zidovudine" post="through lactoferrin nanoparticles during oral administration in ratsPLoS One201510e014039910.1371/journal.pone.014039926461917"/>
  <result pre="transcriptase inhibitory potentialJ Clust Sci20172835936710.1007/s10876-016-1100-1 KumarPLakshmiYSKondapiAKTriple drug combination of zidovudine," exact="efavirenz" post="and lamivudine loaded lactoferrin nanoparticles: an effective nano first-line"/>
  <result pre="potentialJ Clust Sci20172835936710.1007/s10876-016-1100-1 KumarPLakshmiYSKondapiAKTriple drug combination of zidovudine, efavirenz and" exact="lamivudine" post="loaded lactoferrin nanoparticles: an effective nano first-line regimen for"/>
  <result pre="of H1N1 influenza virus infection by selenium nanoparticles loaded with" exact="ribavirin" post="via resisting caspase-3 apoptotic pathwayInt J Nanomedicine2018135787579710.2147/IJN.S17765830310281 LuLSunRWYChenRHuiCKHoCMLukJMLauGKKCheCMSilver nanoparticles"/>
  <result pre="Biol Rev20056946250010.1128/MMBR.69.3.462-500.200516148307 PrathipatiPKMandalSPonGVivekanandanRDestacheCJPharmacokinetic and tissue distribution profile of long acting" exact="tenofovir alafenamide" post="and elvitegravir loaded nanoparticles in humanized mice modelPharm Res2017342749275510.1007/s11095-017-2255-728905173"/>
 </snippets>
</snippetsTree>
